Immunogen
The antiserum was produced against synthesized peptide derived from human KIAA0100. AA range:681-730
Specificity
KIAA0100 Polyclonal Antibody detects endogenous levels of KIAA0100 protein.
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
Immunohistochemistry: 1/100 - 1/300. Immunofluorescence: 1/200 - 1/1000. ELISA: 1/20000. Not yet tested in other applications.
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
sequence caution:Contaminating sequence.,sequence caution:Sequencing errors.,similarity:Belongs to the UPF0378 family.,tissue specificity:Expressed in pancreas, placenta and up-regulated in breast carcinoma epithelial cells, ductal in situ carcinoma (DCIS), invasive breast carcinoma (IBC) and metastatic breast carcinoma cells (MET).,
Function
sequence caution:Contaminating sequence.,sequence caution:Sequencing errors.,similarity:Belongs to the UPF0378 family.,tissue specificity:Expressed in pancreas, placenta and up-regulated in breast carcinoma epithelial cells, ductal in situ carcinoma (DCIS), invasive breast carcinoma (IBC) and metastatic breast carcinoma cells (MET).,
Protein name
UPF0378 protein KIAA0100
Other name
KIAA0100; BCOX1; UPF0378 protein KIAA0100; Antigen MLAA-22; Breast cancer-overexpressed gene 1 protein
Human protein sequence Database
Q14667
Mouse protein sequence database
Q5SYL3
Rat protein sequence database
Cellular localization
Secreted .
Tissue expression
Expressed in pancreas, placenta and up-regulated in breast carcinoma epithelial cells, ductal in situ carcinoma (DCIS), invasive breast carcinoma (IBC) and metastatic breast carcinoma cells (MET).
Contract Us
Follow Us
Location： 
Specification
成功添加到购物车